Trifunctional crosslinking reagents

Active Publication Date: 2014-01-09
ETH ZZURICH
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0023]In further embodiments, the spacer groups S1, S2, S3 are independently of each other (i) a single bond or (ii) a straight-chain or branched, substituted or unsubstituted C(1-24)alkylene, wherein one or more, preferably non-adjacent, —CH2— groups m

Problems solved by technology

This is mainly due to technological limitations in the identification of hydrophobic membrane receptor proteins and due to transient, low affinity interactions of ligands with their corresponding CSRs.
However, the crosslinked peptide species obtained with such molecules are typically of very low relative abundance and the bioinformatic analysis of the mass spectra produced by crosslinked peptides remains a daunting task.
This hampers the identification

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Trifunctional crosslinking reagents
  • Trifunctional crosslinking reagents
  • Trifunctional crosslinking reagents

Examples

Experimental program
Comparison scheme
Effect test

example 1

Synthesis of Crosslinker Joy-06-16

[0212]

(a) Synthesis of (2S)-2-[6-(6-{[(tert-Butoxy)carbonyl]amino}hexanamido)hexanamido]-5-methoxy-5-oxopentanoic Acid (1)

[0213]

[0214]To a solution of (2S)-2-Amino-5-methoxy-5-oxopentanoic acid (9.8 g, 22 mmol; synthesized according to Glenn, M. P. et al, J. Am. Chem. Soc. 2003, 125, 640) in MeOH (130 mL) was added 2,5-Dioxopyrrolidin-1-yl 6-(6-{[(tert-butoxy)carbonyl]amino}hexanamido)hexanoate (5.7 g, 29 mmol; synthesized according to Srinivasan, B. and Huang, X. Chirality 2008, 20, 265) and then to the solution was added TEA (9.4 mL, 67 mmol). After stirring for 30 min at room temperature, the reaction mixture was concentrated under reduced pressure and dissolved in EtOAc (200 mL) and then washed with 1N HCl (100 mL) and washed with brine and dried over MgSO4 and concentrated under reduced pressure and purified by flash chromatography (CH2Cl2:MeOH=10:1 to CHCl3:MeOH:H2O=85:15:1 to CHCl3:MeOH:H2O=65:25:4) providing the desired compound as a white foam

example 2

Synthesis of Crosslinker Joy-05-125

[0237]

(a) Synthesis of tert-Butyl N-[(5S)-5-[(3-{2-[2-({9-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]-5-oxononyl}oxy)ethoxy]ethoxy}propyl)carbamoyl]-5-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pentyl]carbamate (9)

[0238]

[0239]Fmoc-N-ε-Boc-L-Lysine (1.7 g, 3.7 mmol) was dissolved in DMF (20 mL) and then to the solution were added DIPEA (0.63 mL, 3.7 mmol) and HBTU (1.7 g, 4.4 mmol) and after 10 min then to the reaction mixture was added a solution of 1-N-biotinyl-4,7,10-trioxatridecane-1,13-diamine (1.8 g, 4.1 mmol) in DMF (5 mL) and stirred at room temperature for 1 hr and then the solvent was evaporated under reduced pressure and purified by flash chromatography (CHCl3:MeOH:H2O=10:6:1) providing the desired compound as a white viscous foam (2.6 g, 78%).

[0240]TLC (CH2Cl2:MeOH, 10:1 v / v): RF=0.2; 1H-NMR (400 MHz, CD3OD): δ 7.86 (d, J=7.5 Hz, 2H), 7.73 (dd, J=6.5, 4.7 Hz, 2H), 7.48-7.36 (m, 4H), 4.53 (dd, J=7.8, 4.3 Hz, 1H), 4.46 (t

example 3

Ligand-Based Receptor Capturing with Insulin

[0264](a) Ligand Coupling to Trifunctional Cross-Linker Joy-05-125 (Obtained from Example 2)

[0265]50 μg Joy-05-125 (100 mM in DMSO) was added to 100 μg of insulin (I9278, Sigma-Aldrich) in 10 μl HEPES pH8.2 to obtain a ratio of cross-linker:ligand of approximately 2:1. For the control sample, 50 μg Joy-05-125 (100 mM in DMSO) was added to a quenching solution (10 mM Glycine in 10 μl HEPES pH8.2). Reactions were carried out for approximately 1 h at room temperature.

(b) Harvesting of Cells and Oxidation of Cell Surface Glycoproteins.

[0266]2×108 cells (Jurkat T) were collected in a 50 ml tube and washed with phosphate buffered saline (PBS, pH7.4). Subsequently, cells were oxidized for 15 min in the dark at 4° C. with 1.5 mM sodium-meta-periodate (Thermo Scientific) in labeling buffer (PBS, pH6.5). The cell pellet was washed once with 50 ml labeling buffer to remove most of the sodium-meta-periodate and to deplete dead cells / fragments.

(c) Ligan

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to trifunctional crosslinking reagents carrying (i) a ligand-reactive group for conjugation to a ligand of interest having at least one binding site on a target glycoprotein receptor, (ii) an optionally protected aromatic hydrazine group for the capturing of oxidized receptor-glycopeptides and (iii) an affinity group for the detection, isolation and purification of captured glycopeptides, their methods of production, as well as their use in methods for detecting, identifying and characterizing interactions between ligands and their corresponding glycoprotein target receptors on living cells and in biological fluids.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner ETH ZZURICH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products